Please login to the form below

Black Swan Analysis

We are experts in pharmaceutical forecasting with access to proprietary databases of disease-specific patient populations. We understand the limits of knowledge and help predict events that deviate from the expected.

This is a FREE listing




Below are full profiles from other companies in this area

Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and its complexities, Onyx Health helps clients grow their brands and build their reputation to increase their sales.

View profile

OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market access.

View profile

Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance improvement and sustainable growth by working with their leaders and teams to develop excellent strategies, capabilities, and partnerships across commercial, corporate an

View profile

Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient programmes, to designing, developing and testing new materials, we apply the wealth of evidence on what good patient communications look like.

View profile

Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a global scale. We also syndicate our video library in partnership with, and on leading health & medical websites, social networks, and other platforms where healthcare professionals (HCP) & consumers seek relevant content in any language.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we provide custom solutions and strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.

View profile

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals, based in NZ, China, Singapore, UAE, Switzerland, UK and USA.

View profile

Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

View profile

OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes using high quality sales professionals, and multi-channel communication.

View profile

Company Details

Black Swan Analysis

Telephone:+44 (0)1628 621 790

Contact

Address:
Moorbridge Court
29-41 Moorbridge Road Maidenhead
Berkshire
SL6 8LT
UK

Latest content from PMHub

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?
Page & Page
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to get a return on investment.  What are the implications for pharma and biotech market access?
Valid Insight
Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig
Page & Page
SIGHT project team wins top recognition award
SIGHT project team scoops the Bedrock Group CEO Team Award 2019 Bedrock Group